enGene Therapeutics Inc. (ENGN)
Market Closed
1 Sep, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
1. 85
+0.01
+0.8152%
$
123.26M Market Cap
- P/E Ratio
- Div Yield
657,373 Volume
- Eps
$ 1.84
Previous Close Investors:
Want to track ENGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
enGene Therapeutics Inc. (ENGN) Statistics
Valuation metrics
Market Cap 123.26M
Enterprise value 125.78M
Trailing P/E (ttm) -1.38
Forward P/E -
PEG ratio 0.39
Price/Sales (ttm) -
Price/Book (mrq) 0.5
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 855.19K
Average volume (90 days) 795.89K
Price summary
52-Week low 1.4
52-Week high 12.25
Beta -
50-Day moving average 1.8
200-Day moving average 6.27
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.22%
Return on equity -0.29%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.95
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.71
Total debt (mrq) -
Total Debt/Equity (mrq) 0.13
Current ratio (mrq) 12.57%
Book value per share (mrq) 3.66
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
